Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combinatorial phenethyl isothiocyanate and withaferin A targets multiple epigenetics pathways to inhibit MCF-7 and MDA-MB-231 human breast cancer cells. | Cancer Cell Int | 2024 | 39707321 | PubTator, text mining | PubMed |
| A pilot study on the efficacy of a telomerase activator in regulating the proliferation of A375 skin cancer cell line. | Mol Biol Rep | 2024 | 39704853 | PubTator, text mining | PubMed |
| Genome Instability and Senescence Are Markers of Cornelia de Lange Syndrome Cells. | Cells | 2024 | 39682772 | PubTator, text mining | PubMed |
| Repurposed drugs as histone deacetylase 8 inhibitors: Implications in cancer and neuropathological conditions. | Front Pharmacol | 2024 | 39611171 | PubTator, text mining | PubMed |
| Correction: Curcio et al. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods. Pharmaceuticals 2024, 17, 620. | Pharmaceuticals (Basel) | 2024 | 39598470 | PubTator, text mining | PubMed |
| Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations. | Antioxidants (Basel) | 2024 | 39594568 | PubTator, text mining | PubMed |
| Immunometabolism: signaling pathways, homeostasis, and therapeutic targets. | MedComm (2020) | 2024 | 39492834 | PubTator, text mining | PubMed |
| Butyrate Inhibits the HDAC8/NF-κB Pathway to Enhance Slc26a3 Expression and Improve the Intestinal Epithelial Barrier to Relieve Colitis. | J Agric Food Chem | 2024 | 39440960 | PubTator, text mining | PubMed |
| dCas9-HDAC8-EGFP fusion enables epigenetic editing of breast cancer cells by H3K9 deacetylation. | Eur J Cell Biol | 2024 | 39437453 | PubTator, text mining | PubMed |
| Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical models. | J Clin Invest | 2024 | 39436709 | PubTator, text mining | PubMed |
| HDAC8 as a target in drug discovery: Function, structure and design. | Eur J Med Chem | 2024 | 39427514 | PubTator, text mining | PubMed |
| Probing class I histone deacetylases (HDAC) with proteolysis targeting chimera (PROTAC) for the development of highly potent and selective degraders. | Bioorg Chem | 2024 | 39423771 | PubTator, text mining | PubMed |
The identification of potent dual-target monopolar spindle 1 (MPS1) and histone deacetylase 8 (HDAC8) inhibitors through pharmacophore modeling, molecular docking, molecular dynamics simulations, and biological evaluation. | Front Pharmacol | 2024 | 39351092 | PubTator, text mining | PubMed |
| Impact of HDAC inhibitors on macrophage polarization to enhance innate immunity against infections. | Drug Discov Today | 2024 | 39332483 | PubTator, text mining | PubMed |
| ZNF521 promotes acute myeloid leukemogenesis by suppressing the expression and acetylation of SMC3. | Heliyon | 2024 | 39309877 | PubTator, text mining | PubMed |
| Global isonicotinylome analysis identified SMAD3 isonicotinylation promotes liver cancer cell epithelial-mesenchymal transition and invasion. | iScience | 2024 | 39286495 | PubTator, text mining | PubMed |
| N-Myc and STAT Interactor is an Endometriosis Suppressor. | Int J Mol Sci | 2024 | 39125716 | PubTator, text mining | PubMed |
| A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013-present). | Expert Opin Ther Pat | 2024 | 39121339 | PubTator, text mining | PubMed |
| Chromosome X-Wide Common Variant Association Study (XWAS) in Autism Spectrum Disorder. | medRxiv | 2024 | 39108515 | PubTator, text mining | PubMed |
| Anti-tumour activity of Panobinostat in oesophageal adenocarcinoma and squamous cell carcinoma cell lines. | Clin Epigenetics | 2024 | 39097736 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=8